Company: ZLAB
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001628280-25-023411
Chunk: 29

Company: Zai Lab Ltd
Filing Date: 2025-05-08
Form: 10-Q
Item: Part I, Item 1
Chunk 29
---
 respectively)7 7 Additional paid-in capital3,283,800 3,264,295 Accumulated deficit(2,501,521)(2,453,083)Accumulated other comprehensive income49,303 50,515 Treasury Stock (at cost, 4,912,200 shares as of both March 31, 2025 and December 31, 2024)(20,836)(20,836)Total shareholders’ equity810,753 840,898 Total liabilities and shareholders’ equity1,173,330 1,185,753 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

2

Zai Lab Limited 

Unaudited Condensed Consolidated Statements of Operations 

(in thousands of $, except for number of shares and per share data) 

Three Months Ended March 31,Notes20252024RevenuesProduct revenue, net7105,650 87,149 Collaboration revenue7837 — Total revenues106,487 87,149 ExpensesCost of product revenue(38,452)(33,619)Cost of collaboration revenue(195)— Research and development(60,729)(54,645)Selling, general, and administrative(63,422)(69,194)Loss from operations(56,311)(70,309)Interest income8,606 9,658 Interest expenses(1,187)(113)Foreign currency gains (losses)651 (2,068)Other (expense) income, net15(197)9,361 Loss before income tax (48,438)(53,471)Income tax expense8— — Net loss(48,438)(53,471)Loss per share - basic and diluted9(0.04)(0.05)Weighted-average shares used in calculating net loss per ordinary share - basic and diluted 1,080,825,300 973,145,760 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. 

3

Zai Lab Limited 

Unaudited Condensed Consolidated Statements of Comprehensive Loss 

(in thousands of $) 

Three Months Ended March 31,20252024Net loss(48,438)(53,471)Other comprehensive income, net of tax of nil:Foreign currency translation adjustments(1,212)1,542 Comprehensive loss(49,650)(51,929)